Endurance Exercise for Obesity
(ATLAS Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores how regular endurance exercise (also known as aerobic or cardiovascular exercise) can improve fat tissue quality and the body's insulin response, which affects blood sugar levels. Participants will either join an exercise program or be in a control group for comparison. The trial seeks men and pre-menopausal women living with obesity, with a BMI between 30 and 40, who have not exercised regularly more than once a week over the past year. The study aims to better understand how exercise impacts health, potentially offering new insights for managing obesity. As an unphased trial, it provides participants the chance to contribute to groundbreaking research that could lead to new strategies for managing obesity.
Will I have to stop taking my current medications?
The trial does not specify if you must stop taking your current medications, but certain medications are exclusionary, such as those for cardiovascular, psychiatric, pulmonary, hormonal, and other conditions. If you are on any of these medications, you may not be eligible to participate.
What prior data suggests that endurance exercise is safe for improving adipose tissue quality and insulin sensitivity?
Research has shown that endurance exercise is generally very safe for most people. Studies have found that regular aerobic exercise, such as endurance workouts, offers significant health benefits, including improved heart health and reduced body fat. For example, engaging in at least 150 minutes of aerobic exercise each week can help reduce waist size and lower body fat.
Research also suggests that endurance exercise boosts overall heart and blood vessel health, helping them remain strong with age. Additionally, it can enhance the function of mitochondria, the tiny structures in cells that produce energy.
The sources provided do not indicate specific evidence of harm from endurance exercise, and it is generally well-tolerated. However, as with any activity, it's important to pay attention to the body's signals and consult a healthcare professional before starting a new exercise program.12345Why are researchers excited about this trial?
Researchers are excited about endurance exercise for obesity because it offers a natural and accessible way to tackle the condition without relying on medications or surgical interventions. Unlike medications that may come with side effects or require long-term use, endurance exercise improves cardiovascular health and increases metabolism by boosting the body's ability to burn fat. Moreover, this approach empowers individuals to adopt a healthier lifestyle, potentially leading to sustainable weight management and overall well-being.
What evidence suggests that endurance exercise is effective for obesity?
This trial will compare the effects of endurance exercise with a control group. Studies have shown that regular endurance exercise can greatly improve health in people with obesity. Research indicates that aerobic exercise, such as endurance training, helps reduce waist size and body fat. Evidence also shows that it improves the body's insulin use, which is crucial for controlling blood sugar levels. Endurance exercise is linked to numerous health benefits, including a healthier heart and a lower risk of obesity-related diseases, such as type 2 diabetes. Overall, endurance exercise is a proven method to enhance fat burning and insulin use in the body.12678
Who Is on the Research Team?
Lauren Sparks, PhD
Principal Investigator
AdventHealth Translational Research Institute
Ursula White, PhD
Principal Investigator
Pennington Biomedical Research Center
Are You a Good Fit for This Trial?
This trial is for men and pre-menopausal women aged 18-45 with obesity (BMI of 30.0-40.0), leading a sedentary lifestyle, who haven't had significant weight or lifestyle changes recently. Participants must understand English, agree to use birth control if applicable, and commit to the study's procedures.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo endurance exercise training or control (no exercise) for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Endurance Exercise
Find a Clinic Near You
Who Is Running the Clinical Trial?
AdventHealth Translational Research Institute
Lead Sponsor
Pennington Biomedical Research Center
Collaborator